A

Aquestive Therapeutics

D
AQST
USD
0.02
(0.3949%)
Market Closed
51,320.00
Volume
-0.46
EPS
-
Div Yield
-14.125000
P/E
463,038,879.60
Market Cap
Today
0.3949%
1 Week
-7.629%
1 Month
4.954%
6 Months
50.000%
12 Months
192.241%
Year To Date
151.733%
All Time
-66.213%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
B
BHC
-0.075
(-0.7891%)
USD
B
BMRN
0.785
(1.1869%)
USD
O
OMER
0.12
(2.7366%)
USD
S
SRNE
(%)
USD
S
SUPN
-1.365
(-3.6159%)
USD
V
VKTX
2.97
(4.5075%)
USD
R
RUBY
(%)
USD
L
LQDT
0.28
(1.1676%)
USD
L
LXRX
0.08
(6.639%)
USD

Title:
Aquestive Therapeutics

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
Do you need help or have a question?
Contact Us